COHEN ROBERT,CARR SUZETTE,HAGERTY DAVID,BECKER JEAN-CLAUDE,PEACH ROBERT J.
申请号：
PL38900201
公开号：
PL212205B1
申请日:
2001.07.02
申请国别(地区):
PL
年份:
2012
代理人:
摘要：
The present invention relates to compositions and methods for treating rheumatic disease by administering to a subject, soluble CTLA4 mutant molecules that block endogenous B7 molecules from binding their ligands.
